Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 3736 AL 3750

Implications of Tau Dysregulation in Huntington's Disease and Potential for New Therapeutics

Mees I, Nisbet RM, Hannan AJ, Renoir T.

J Huntingtons Dis. 2023;12(1):1-13. doi: 10.3233/JHD-230569.

Automated system for training and assessing string-pulling behaviors in rodents

Jordan GA, Vishwanath A, Holguin G, Bartlett MJ, Tapia AK, Winter GM, Sexauer MR, Stopera CJ, Falk T, Cowen SL.

bioRxiv [Preprint]. 2023 Jul 31:2023.07.02.547431. doi: 10.1101/2023.07.02.547431.

Quality of life, health-related quality of life, and associated factors in Huntington's disease: a systematic review

van Lonkhuizen PJC, Frank W, Heemskerk AW, van Duijn E, de Bot ST, Mühlbäck A, Landwehrmeyer GB, Chavannes NH, Meijer E; HEALTHE-RND consortium.

J Neurol. 2023 May;270(5):2416-2437. doi: 10.1007/s00415-022-11551-8. Epub 2023 Jan 30.

Tunneling Nanotube: An Enticing Cell-Cell Communication in the Nervous System

Dagar S, Subramaniam S.

Biology (Basel). 2023 Sep 27;12(10):1288. doi: 10.3390/biology12101288.

Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials

Andrade S, Nunes D, Dabur M, Ramalho MJ, Pereira MC, Loureiro JA.

Pharmaceutics. 2023 Jan 7;15(1):212. doi: 10.3390/pharmaceutics15010212.

Neuron-astrocyte omnidirectional signaling in neurological health and disease

Pathak D, Sriram K.

Front Mol Neurosci. 2023 Jun 8;16:1169320. doi: 10.3389/fnmol.2023.1169320. eCollection 2023.

Challenges and Discoveries in Polypharmacology of Neurodegenerative Diseases

Lustoza Rodrigues TCM, de Sousa NF, Dos Santos AMF, Aires Guimarães RD, Scotti MT, Scotti L.

Curr Top Med Chem. 2023;23(5):349-370. doi: 10.2174/1568026623666230126112628.

Sleep Dysfunction in Huntington's Disease: Impacts of Current Medications and Prospects for Treatment

Owen NE, Barker RA, Voysey ZJ.

J Huntingtons Dis. 2023;12(2):149-161. doi: 10.3233/JHD-230567.

Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington's Disease and Tardive Dyskinesia

Frank S, Alakkas A.

Ther Clin Risk Manag. 2023 Dec 1;19:1019-1024. doi: 10.2147/TCRM.S279332. eCollection 2023.

GLUT-1 changes in paediatric Huntington disease brain cortex and fibroblasts: an observational case-control study

Tramutola A, Bakels HS, Perrone F, Di Nottia M, Mazza T, Abruzzese MP, Zoccola M, Pagnotta S, Carrozzo R, de Bot ST, Perluigi M, van Roon-Mom WMC, Squitieri F.

EBioMedicine. 2023 Nov;97:104849. doi: 10.1016/j.ebiom.2023.104849. Epub 2023 Oct 26.

Functional Implications of Protein Arginine Methyltransferases (PRMTs) in Neurodegenerative Diseases

Angelopoulou E, Pyrgelis ES, Ahire C, Suman P, Mishra A, Piperi C.

Biology (Basel). 2023 Sep 20;12(9):1257. doi: 10.3390/biology12091257.

The Role of Voltage-Gated Calcium Channels in Basal Ganglia Neurodegenerative Disorders

Correa BHM, Moreira CR, Hildebrand ME, Vieira LB.

Curr Neuropharmacol. 2023;21(2):183-201. doi: 10.2174/1570159X20666220327211156.

TRP channels: Role in neurodegenerative diseases and therapeutic targets

Rather MA, Khan A, Wang L, Jahan S, Rehman MU, Makeen HA, Mohan S.

Heliyon. 2023 Jun 2;9(6):e16910. doi: 10.1016/j.heliyon.2023.e16910. eCollection 2023 Jun.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias